arXiv · 2202.13338
A one-size-fits-all artificial pancreas for people with type 1 diabetes based on physiological insight and feedback control
Abstract
We propose a model-free artificial pancreas (AP) for people with type 1 diabetes. The algorithmic parameters are tuned to a virtual population of 1,000,000 individuals, and the AP repeatedly estimates the basal and bolus insulin requirements necessary for maintaining normal blood glucose levels. Therefore, the AP can be used without healthcare personnel or engineers customizing the algorithm to each user. The estimates are based on bodyweight, measurements from a continuous glucose monitor (CGM), and estimates of the meal carbohydrate contents. In a virtual clinical trial with all 1,000,000 individuals (i.e., a Monte Carlo closed-loop simulation), the AP achieves a mean time in range of more than 87% and almost 89% of the participants satisfy several glycemic targets.
Explore related subjects
Keep this discovery
Tobias K. S. Ritschel, Asbjørn Thode Reenberg, Emilie B. Lindkvist, Christian Laugesen, Jannet Svensson, Ajenthen G. Ranjan, Kirsten Nørgaard, Bernd Dammann, John Bagterp Jørgensen. 2022-02-27. A one-size-fits-all artificial pancreas for people with type 1 diabetes based on physiological insight and feedback control. https://arxiv.org/abs/2202.13338
Cite the original work for its findings. Save a collection to share your selection of sources.